RheumaGen
Background
By identifying that Human Leukocyte Antigens (HLA) play a key role in the genetic origin of autoimmune diseases, RheumaGen is revolutionizing the field of autoimmunity by developing a unique, revolutionary technology that targets the HLA gene itself, using gene editing to turn off the genetic trigger causing the immune system to attack healthy cells.
Back to Portfolio